ZYNE

Zynerba Pharmaceuticals Stock Price

3.29
0.06 (1.86%)
Upgrade to Real-Time
Regular Market
3.29
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Zynerba Pharmaceuticals Inc ZYNE NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.06 1.86% 3.29 10:29:23
Close Price Low Price High Price Open Price Previous Close
3.21 3.32 3.22 3.23
Bid Price Ask Price Spread News
3.26 3.29 0.03 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
462 94,047 $ 3.26 $ 306,262 541,449 2.55 - 8.83
Last Trade Time Type Quantity Stock Price Currency
10:29:23 100 $ 3.29 USD

Zynerba Pharmaceuticals Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 96.25M 29.26M 25.92M $ - $ - -1.52 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - 7.30%

more financials information »

Zynerba Pharmaceuticals News

Date Time Source News Article
9/17/202013:55GlobeNewswire Inc.Zynerba Pharmaceuticals Receives Orphan Drug Designation for..
9/14/202007:02Edgar (US Regulatory)Current Report Filing (8-k)
9/14/202006:55GlobeNewswire Inc.Zynerba Pharmaceuticals Provides Update on Recent Milestones
9/10/202007:30GlobeNewswire Inc.Zynerba Pharmaceuticals to Present at Two Upcoming Virtual..
8/10/202009:28Edgar (US Regulatory)Quarterly Report (10-q)
8/10/202006:45GlobeNewswire Inc.Zynerba Pharmaceuticals Reports Second Quarter 2020..
8/06/202007:00GlobeNewswire Inc.Zynerba Pharmaceuticals to Present at the Virtual 40th..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ZYNE Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week3.773.793.163.44567,337-0.48-12.73%
1 Month3.824.043.163.64528,343-0.53-13.87%
3 Months3.504.403.123.67724,978-0.21-6.0%
6 Months3.927.792.804.501,149,017-0.63-16.07%
1 Year7.658.832.554.96870,462-4.36-56.99%
3 Years6.2216.472.558.11883,754-2.93-47.11%
5 Years17.919925.952.559.24664,525-14.63-81.64%

Zynerba Pharmaceuticals Description

Zynerba Pharmaceuticals Inc together with its subsidiary is a pharmaceutical company which is focused on developing and commercializing proprietary next generation synthetic cannabinoid therapeutics formulated for transdermal delivery. Its product candidates are ZYN001 and ZYN002. The company has initiated a clinical trial for both the product candidates.
Your Recent History
NASDAQ
ZYNE
Zynerba Ph..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200925 14:45:01